Federal Register / Vol. 60, No. 9 / Friday, January 13, 1995 / Notices 3249

Centers for Disease Control and

Prevention

Technical Advisory Committee for

Diabetes Translation and Community

Control Programs; Meeting

In accordance wtih section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting.

Name: Technical Advisory Committee for

Diabetes Translation and Community Control

Programs.

Time and Date: 8:30 a.m.-4:30 p.m.,

Monday, January 30, 1995.

Place: Rhodes Building, 4th Floor

Conference Room, 3005 Chamblee-Tucker

Road, Atlanta, Georgia 30341, telephone 404/

488–5000. (Exit Chamblee-Tucker Road off I–

85).

Status: Open to the public, limited only by

the space available.

Purpose: This committee is charged with

advising the Director, CDC, regarding

priorities and feasible goals for translation

activities and community control programs

designed to reduce risk factors, morbidity,

and mortality from diabetes and its

complications. The committee advises

regarding policies, strategies, goals and

objectives, and priorities; identifies research

advances and technologies ready for

translation into widespread community

practice; recommends public health

strategies to be implemented through

community interventions; advises on

operational research and outcome evaluation

methodologies; identifies research issues for

further clinical investigation; and advises

regarding the coordination of programs with

Federal, voluntary, and private resources

involved in the provisions of services to

people with diabetes.

Matters to be Discussed: Committee

members will discuss CDC’s role in primary

prevention, the National Diabetes Education

Program, screening issues, the Regenstreif

Conference, Policy and economic activities,

and the status of the Diabetes Control

Programs and health communication.

Agenda items are subject to change as

priorities dictate.

Contact Person For More Information:

Cheryl Shaw, Program Specialist, Division of

Diabetes Translation, National Center for

Chronic Disease Prevention and Health

Promotion, CDC, 4770 Buford Highway, NE,

(K–10), Atlanta, Georgia 30341–3724,

telephone 404/488–5004.

Dated: January 9, 1995.

William H. Gimson,

Acting Associate Director for Policy

Coordination, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 95–886 Filed 1–12–95; 8:45 am]

BILLING CODE 4163–18–M

Poverty-Associated Mental Retardation

Prevention Technical Assistance

Workshop; Meeting

The National Center for

Environmental Health (NCEH), Centers

for Disease Control and Prevention

(CDC), announces the following

meeting.

Name: Poverty-Associated Mental

Retardation (PAMR) Prevention Technical

Assistance Workshop for Planning Grant

Recipients.

Time and Date: 8:30 a.m.–4:30 p.m.,

January 30, 1995.

Place: Swissotel Atlanta, 3391 Peachtree

Road, NE, Atlanta, Georgia 30326.

Status: Open to the public limited only by

the space available.

Purpose: The primary purpose of this

workshop is to provide technical assistance

to recipients of CDC grants as they plan

programs to prevent PAMR. The workshop is

not designed to provide general information

on mental retardation or on prevention of

PAMR.

Supplementary Information: The workshop

will convene a group of recipients of CDC

PAMR Planning Grants.

Seven of every 1,000 ten-year old children

suffer from mild mental retardation, and

three of every 1,000 suffer from more serious

mental retardation. Poor children, especially

those whose mothers have less than a high

school education, are at risk for cognitive

delay of as much as one standard deviation

of IQ (15 points) at age three. Studies such

as the Infant Health and Development

Program and the Carolina Abecedarian

Project have proven that an intensive early

health and development intervention can

prevent or reduce as much as two-thirds of

PAMR. CDC is actively involved in research

and planning to help States develop a

community-based program to prevent PAMR.

Contact Person for Additional Information:

Edward A. Brann, M.D., Chief, Mental

Retardation Prevention Section,

Developmental Disabilities Branch, Division

of Birth Defects and Developmental

Disabilities, NCEH, CDC, Mailstop F–15,

4770 Buford Highway, NE, Atlanta, Georgia

30341–3724, telephone 404/488–7400.

Dated: January 6, 1995.

William H. Gimson,

Acting Associate Director for Policy

Coordination, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 95–883 Filed 1–12–95; 8:45 am]

BILLING CODE 4163–18–M

Food and Drug Administration

[Docket No. 94F–0455]

American Science and Engineering,

Inc.; Filing of Food Additive Petition

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that American Science and Engineering,

Inc., has filed a petition proposing that

the food additive regulations be

amended to provide for the safe use of

X-radiation, produced by the operation

of X-ray tubes at energy levels of

500,000 electron volts (500 keV) or

lower, to inspect cargo containers that

may contain food.

DATES: Written comments on the

petitioner’s environmental assessment

by February 13, 1995.

ADDRESSES: Submit written comments

to the Dockets Management Branch

(HFA–305), Food and Drug

Administration, rm. 1–23, 12420

Parklawn Dr., Rockville, MD 20857.

FOR FURTHER INFORMATION CONTACT:

Patricia A. Hansen, Center for Food

Safety and Applied Nutrition (HFS–

206), Food and Drug Administration,

200 C St. SW., Washington, DC 20204,

202–418–3098.

SUPPLEMENTARY INFORMATION: Under the

Federal Food, Drug, and Cosmetic Act

(sec. 409(b)(5) (21 U.S.C. 348(b)(5))),

notice is given that a food additive

petition (FAP 5M4438) has been filed by

American Science and Engineering Inc.,

40 Erie St., Cambridge, MA 02139–4286.

The petition proposes to amend the food

additive regulations in § 179.21 Sources

of radiation used for inspection of food,

for inspection of packaged food, and for

controlling food processing (21 CFR

179.21) to provide for the safe use of Xradiation, produced by the operation of

X-ray tubes at energy levels of 500 keV

or lower, to inspect cargo containers

that may contain food.

The potential environmental impact

of this action is being reviewed. To

encourage public participation

consistent with regulations promulgated

under the National Environmental

Policy Act (40 CFR 1501.4(b)), the

agency is placing the environmental

assessment submitted with the petition

that is the subject of this notice on

display at the Dockets Management

Branch (address above) for public

review and comment. Interested persons

may, on or before February 13, 1995,

submit to the Dockets Management

Branch (address above) written

comments. Two copies of any comments

are to be submitted, except that

individuals may submit one copy.

Comments are to be identified with the

docket number found in brackets in the

heading of this document. Received

comments may be seen in the office

above between 9 a.m. and 4 p.m.,

Monday through Friday. FDA will also

place on public display any

amendments to, or comments on, the